{"name":"Versiti Blood Health","slug":"versiti-blood-health","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"efanesoctacog alpha","genericName":"efanesoctacog alpha","slug":"efanesoctacog-alpha","indication":"Hemophilia B (Factor IX deficiency) for routine prophylaxis and treatment of bleeding episodes","status":"marketed"}]}],"pipeline":[{"name":"efanesoctacog alpha","genericName":"efanesoctacog alpha","slug":"efanesoctacog-alpha","phase":"marketed","mechanism":"Efanesoctacog alpha is a recombinant fusion protein that bridges Factor IXa and Factor X to restore the intrinsic tenase complex activity in patients with hemophilia B.","indications":["Hemophilia B (Factor IX deficiency) for routine prophylaxis and treatment of bleeding episodes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQenJPSy11T3g4NUNKbm54bDM1eHpJS1RBTmM3ZFNZdXpuRXoxTGhuWVkzcU54UlNwLWFFR2V1OWt6SUU5M3djMFVjMkFqWHJkc05aVkRRUGJwdDRQUWlyTDZvSm1OQlJTSnVJSy1pUE1yYTVONHFCYmwwNFVkaXNLT3hfVnExOFFHLWJDTTUzYWN0dnlwYzlrWG5ZMmx3UGV1RmtlNXpIWEtud3FXeF9OazhUSk81VTBmRkx0Ujh6RXNqTHl6ZjBPcVdfT1BPS0F3RnBHYTVxeGZWLVkxcFljUUM5N1FXYWZMSlljT1FwVQ?oc=5","date":"2026-03-03","type":"pipeline","source":"PR Newswire","summary":"MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute - PR Newswire","headline":"MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQUllaRkI5eVhNUU9LbkkzVDdCU2RXRUdBLXJKeEZUeEN2eGlQZE1nYUJjOVdORXN6TU41bklYdVU1S1J0UC1mMEVVU29LOEhxNUttZmJQa3FpSlBoOFhBNFdQTFFQQXVCWUlSd1RlbjVPZEZqbnZpWVllcWRxMmhYMGY0MXZyd3E1bGxiUnlmdXp6eV9IUlIteHg5elh5eVIteklmai01UVJCQV9Nd25EOVo0bHVtZHBibWJPaTd2UlR0Ri1UUFZBLXlabk8xY0hLT3RBdm1iaw?oc=5","date":"2026-02-04","type":"pipeline","source":"PR Newswire","summary":"Federal Funding Bill Commits $3 Million to Versiti Blood Research Institute Expansion - PR Newswire","headline":"Federal Funding Bill Commits $3 Million to Versiti Blood Research Institute Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOODJOR3VKeTAxV2xLTEdGX3BqcWxSejc4bHp0UGV0MDRkeldVSjlzT0NTTmdld1lNalMxT3BkVHpMeUx6VU15eGVzQnVFRUxSTzhURE5KenpWbUdIWTBCNFhOLWVMNU5TVHhHQWtKTTExY3pMM2ZSWUF2ZUl1Wkh4T3V3QURsLWNiSkFiQkVWbkl1amNSYXJpU0h5Y0syX1IwbkVla203QWI5T1lja1RONmw5a2hzTUk?oc=5","date":"2024-11-04","type":"deal","source":"PR Newswire","summary":"Versiti Blood Center of Ohio to Acquire Solvita Blood Center - PR Newswire","headline":"Versiti Blood Center of Ohio to Acquire Solvita Blood Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPTXB1VE5sOVg1ZUNpUHM2dnEzM19mazdjVzNxZWIzRTdHaE0xYjdCRko5V1hmbU9hQVh0bF9aaXNvZTdQZF9wcVZPUUNaOXdDN25qYThKUXN2N1pEa3RzektTSWRfektkQ1Vld1dQVjE4RkQ2aWdoSk9sYjlRNUJMdy05b3AyRldVYU56UzYtamVHUUlsOXBGcFEwd0F0Z1ljbDlDbnl5VGFIaDZmNWdsRk5EQ3gtblQwTm1WNjJTR25ZU19aZ092WVpxZ3lsaW85NGtNQVVOdw?oc=5","date":"2024-10-16","type":"pipeline","source":"PR Newswire","summary":"Versiti teams with Velico and participates in Velico's Blood Center Education Program - PR Newswire","headline":"Versiti teams with Velico and participates in Velico's Blood Center Education Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPQlpQaG50d1FXTGtOclhUOEZqaXdBU0ZUZjVoZWZYOFNOLXNKcUVOUzdGd2oxOGtJOElxVExxODFIX19sX2ZWV2NDWklyNEVfYmFqQVBMNkJjZGJ1bWJlbGlOU2NlYmFNd1FsSjMtS1AtOEtEdllNUmEyakNldkp2VXpaelBlTHg2QzQ1TlJuTFR3SzZOVF94aFJyV3hMM0pGbEZWMXhHS1A2cUNTUGQ2akNyS1VNYXlPZUlaOHJ4bHJkQm4wSzRzQXk4czVHZVhLWkE?oc=5","date":"2024-07-23","type":"pipeline","source":"PR Newswire","summary":"Versiti, Inc. Names Matthew Anderson, MD, PhD, Executive VP and Chief Medical Officer - PR Newswire","headline":"Versiti, Inc. Names Matthew Anderson, MD, PhD, Executive VP and Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQM2lRajRyOThQc1dTeVl3Wm1PVTRxNVpkWllYNHBEY2VrR3h3UWhDdE00NHRlaWRtWTFZUEoyN21GWjNHOU4waE81amlIemwyZEVnU3pIWkJiZU43dGNyc2gyZUg4MWRKc2NpWlNBdFJuQXFjdFhpVGhSSmdkR09mekx3MUl6SUlNdU1DTmJraXdEWE02MU4zNXdpUnRvblUwbGfSAaoBQVVfeXFMT0tReHhzY21aZXRacTFSam91VVlSUmRxOGVaRk5lR1ZfZ3BUbjdrRzctMkQyMDBNZE8wYVVZNXpMOFd0RS1Fc1dzMWFOSnNJemd6cHhmd2g1dmRKTWRPUk1wemFoNlZkeWRtWGljM0hlUG9HYXByLW1ZM2c5YklmdGN6VkgtYkRXSWtoekJKUS1xOUNRUmhfUlJhSkNVdkhpRzhmOWFlVzlIaVE?oc=5","date":"2024-05-19","type":"pipeline","source":"BizTimes - Milwaukee Business News","summary":"In their blood: Versiti makes huge impact on health care and Milwaukee’s economy - BizTimes - Milwaukee Business News","headline":"In their blood: Versiti makes huge impact on health care and Milwaukee’s economy - BizTimes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOdEFRVTVQdWFSVEJtOHo3WG92WURGOE5DUjN1WGx0TEsxRUlGbEt3WXBMUEdvX0NUdXNabk9UN2syZHE3V2RyYXdiYktHM2d5MlhNUG5LNlRRTUV0UTFTWUpzNkhQX0dkU0pNUnZSMktrQ3ZfUHNrU3djdUlMaU8zUkxVY0FnMlFqWW90WjhTZ3lXNGg4N2UxZTNSSGNnZ19EdUdYRlBPdlVDcS1WdkRCcHEteWExSTg5MEdIaS02bUwzQ1lXUXJMSXQtY19tX1QwZ2NoaVQ4dGlnSi1JVTdv?oc=5","date":"2024-03-26","type":"pipeline","source":"PR Newswire","summary":"Gretchen Jameson Named Executive Vice President and Chief Marketing Officer of Versiti, Inc. - PR Newswire","headline":"Gretchen Jameson Named Executive Vice President and Chief Marketing Officer of Versiti, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQOTExSkRDZmxnYnJySTFhM19rRDl2Y3VSNzA3RHUyT1liSW5rT0lPd3BzejF5QXRJcVBOcHFfYUFkTnBHaWZIZGNGd2w0ektaTFQtTVRCQ0FHNFlpV0JocFlvQnd0dFBLSjhGd1Q5aGFmZndKa2t1RDZRSlBRVkxiUXc3V3FQN3duN180SmF2NXA5TmR1MlU1TGpEVGVRSUxxUlMxclhvTTZGbTFZZkZFREloRWNBa2dfMnR6a2luRXY3andoS3pnRTgwbHRCYTY2MktsbWEwbw?oc=5","date":"2024-03-14","type":"pipeline","source":"PR Newswire","summary":"Derek Tyus Named Executive Vice President and Chief Financial Officer of Versiti, Inc. - PR Newswire","headline":"Derek Tyus Named Executive Vice President and Chief Financial Officer of Versiti, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOOFNIbWFNR1AwcFpLd1VyU05HNWZrMkRpTHBmQjRab0w3d0J3MHJ3ZnA5aW9VUUdwSmJYNnViRmRybzRZUWdEcEo3REhRZXpDcUU2UUpHWGI1elJKdjhLX1hUZjVQZm9Vdm96N2JVSm9WZjh5R2U1eUJNNVBYZEJldGYwSkw4Tkd3UE0wTXlfQXl3a0xUc29BTkJOQ2E1c0RvOUE?oc=5","date":"2023-07-11","type":"deal","source":"The Business Journals","summary":"Versiti acquires Indiana biosciences firm Quantigen - The Business Journals","headline":"Versiti acquires Indiana biosciences firm Quantigen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxORWZ3S0lnZ3F5RUNuVGY0OXJxMEVNdk5GaERVN3BybHJITzRiQl9kRzFCQl9sYUpUZzgxRmhicW5JMHY0TDhBMGV2SUd3bWRDTDQ2dWJRU1FfeFhLYVFPdTVDNldGMk14TWZ5cEdkQ25oTUpPTHhMX1RBM0lHdnJ4SVlhQ2xJRVY5ZDkzaHJadzZ2cmpVZmJlejFJMTM?oc=5","date":"2023-07-10","type":"deal","source":"PR Newswire","summary":"Versiti Acquires Indiana-based Quantigen - PR Newswire","headline":"Versiti Acquires Indiana-based Quantigen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOOG0tckR2M3pDVjctZHllMEhJWS1GYTJZbkpicVpla3M2T2lHV2lUUmJPcGZnbGRqZ18tUnVMYWl2ZjliaWN5MER0eHJZYzdTdndkQms1NEU4b21IZlgycVFacEhyOUg1OVU5WFdzUnA2MERGSU5KTnhVMEVjcmE5b3lDa2QtSEFwQlN3c21jT0JxTjJtUWcwZnRZNnFKem01RGRoZUlrZnFHT3Nod3BDbjFWM0V2QXFsTWJ4SkxmNG5qdUU2TlE?oc=5","date":"2022-07-12","type":"deal","source":"PR Newswire","summary":"Versiti Acquires Missouri-based Ethical and Independent Review Services - PR Newswire","headline":"Versiti Acquires Missouri-based Ethical and Independent Review Services","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOMmprT0ljVE1INk9tVF9mMHpXd3VFa3RaSkRvZV9TY0gzdjR5OUdtcUNxLVVlMEtGSVpBRTJ4VERYUDhJNWlFMUdsZV9kWGl4M1VpZy1PSWRKMFdjanRmbU00ejV4VGdtQ0ZVXzdRZnhkMldCdjEwYmxlQXVmVWtLWmNQX3hPS0xJcTd5bDF3ZUxTeHFXdzZLa1M3Z0FLRS1UQTZhTlZ2d0tuOG41NHNXcVpTdE5Xek1QWWI5cHk0RTB0cFNMWXc?oc=5","date":"2018-10-25","type":"pipeline","source":"BioSpace","summary":"Versiti's Blood Research Institute receives one million dollar gift from Stollenwerk Family Foundation - BioSpace","headline":"Versiti's Blood Research Institute receives one million dollar gift from Stollenwerk Family Foundation","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}